Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.69    
    

INTERMUNE, INC.

Stock Bonus Award Agreement  

        This STOCK BONUS AWARD AGREEMENT (the "Award Agreement"), is made effective as of November 5, 2003 between
INTERMUNE, INC., a Delaware corporation (the "Company"), and WILLIAM R. RINGO, JR. (the
"Participant"). This Award Agreement is made pursuant to the terms of the Company's 2000 Equity Incentive Plan (the
"Plan"). The applicable terms of the Plan are incorporated herein by reference, including the definition of terms contained in the Plan. 

        Section 1.    Award Shares.    The Company awards to the Participant, on the terms and conditions hereinafter
set forth, a stock bonus award with respect to 25,000 shares of the Common Stock of the Company (the "Award Shares"). 

        Section 2.    Vesting Requirements.    

        (a)    Vested Award Shares.    On the date hereof, 6,250 of the Award Shares shall be fully vested. 

        (b)    Vesting Schedule.    Subject to the remaining paragraphs of this Section 2 and Sections 3 and 4 hereof,
the unvested Award Shares shall become vested, so long as the Participant continues to provide services to the Company as Chairman of the Board of Directors (the
"Board") as of the applicable vesting date, as follows: 

	(1)
	On
December 25, 2003 (the "Initial Vesting Date"), 1,563 of the Award Shares shall vest; and

	(2)
	An
additional 1,563 of the Award Shares shall vest quarterly after the Initial Vesting Date, with the final such vesting date occurring on June 25, 2006
(i.e. the additional vesting dates shall occur on March 25, June 25, September 25 and December 25 of each such year
commencing on March 25, 2004 and ending on June 25, 2006); and

	(3)
	On
September 25, 2006, the remaining 1,557 unvested Award Shares shall vest. 

        (c)    Termination of Service.    If the Participant's service as Chairman of the Board is terminated by the Company
other than "for Cause" (as defined in subsection 2(g) below) after the date hereof, all Award Shares shall become immediately vested and nonforfeitable. If the Participant's service as Chairman
of the Board is terminated by the Company for Cause or by the Participant for any reason (or no reason) after the date hereof, the Participant shall forfeit his interest in all unvested Award Shares. 

        (d)    Forfeited Shares.    Any Award Shares that are forfeited by the Participant hereunder shall be returned and
transferred to the Company without consideration paid to the Participant, and the Participant shall cease for all purposes to be a shareholder of such shares as of the date of termination of service. 

        (e)    Change in Control.    All unvested Award Shares shall become fully and immediately vested and nonforfeitable
upon the occurrence of a Change in Control (as defined below) prior to any scheduled vesting date, provided that such Award Shares have not been forfeited prior to the effective date of such Change in
Control. A "Change in Control" means (i) a sale, lease or other disposition of all or substantially all of the securities or assets of the
Company, (ii) a merger or consolidation in which the Company is not the surviving corporation or (iii) a reverse merger in which the Company is the surviving corporation but the shares
of Common Stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise. 

        (f)    Death.    Notwithstanding the provisions of Section 2(b) hereof, all unvested Award Shares shall become
fully and immediately vested and non-forfeitable upon the occurrence of the Participant's death prior to any scheduled vesting date, provided that such Award Shares have not been forfeited
prior to the date of such death. 

 

        (g)    Definition of "For Cause."    Termination "for Cause" means a
termination by the Company of the Participant's service to the Company as Chairman of the Board based on a determination that any one or more of the following has occurred: 

	•
	Willful
refusal to follow lawful and reasonable corporate policy or Board directives;

	•
	Willful
failure, gross neglect or refusal to perform duties;

	•
	Willful
act that intentionally and materially injures the reputation or business of the Company;

	•
	Willful
breach of confidentiality that has a material adverse affect on the Company;

	•
	Fraud
or embezzlement; or

	•
	Indictment
for criminal activity. 

For
purposes of this definition of "for Cause," no act or failure to act shall be considered "willful" unless it was done or omitted to be done not in good faith, and shall not include any act or
failure to act resulting from the Participant's disability. Furthermore, a termination for Cause shall not take effect unless the Participant is given written notice by the Company of its intention to
terminate the Participant for Cause, and is given to the Participant within 90 days of the Company's learning of such act or acts or failure or failures to act. You shall then have
20 days after the date that such written notice has been given to the Participant in which to cure such conduct, to the extent such cure is possible. If the Participant fails to cure such
conduct, the Participant shall then be entitled to a hearing before the Board at which the Participant and the Participant's counsel are entitled to appear. Such hearing shall be held within
25 days of such notice to the Participant, provided the Participant requests such hearing within 10 days of the written notice from the Company of the intention to terminate the
Participant for Cause. If, within five days following such hearing, the Participant is furnished written notice by the Board confirming that, in its judgment, grounds for Cause on the basis of the
original notice exist, the Participant shall then be terminated for Cause. For purposes of such determination by the Board, at least 75% of the Board, not including the Participant, voting on the
issue of the
Participant's termination must find that there were grounds on which to terminate the Participant for Cause. 

        Section 3.    Rights as a Shareholder.    Subject to the otherwise applicable provisions of the Plan and this
Award Agreement, the Participant shall have all rights of a shareholder with respect to the Award Shares, including the right to vote the shares and receive all dividends and other distributions paid
or made with respect thereto. 

        Section 4.    Restrictions on Transfer.    Neither this Award Agreement nor any Award Shares covered hereby may
be sold, assigned, transferred, encumbered, hypothecated or pledged by the Participant, otherwise than to the Company, unless as of the date of any such sale, assignment, transfer, encumbrance,
hypothecation or pledge, such Award Shares to be thus disposed of have become vested in accordance with this Award Agreement. The certificate or certificates representing shares delivered pursuant to
the Award Agreement shall bear a legend referring to the nontransferability or assignability of such shares pursuant to this Section 4, and a stop-transfer order against such
certificate or certificates will be placed by the Company with its transfer agents and registrars. At the discretion of the Board, in lieu of issuing a stock certificate to the Participant, the
Company or its designated agent may hold the Award Shares in escrow during the period such shares remain subject to the vesting restrictions and other restrictions provided hereunder. 

        Section 5.    Award Subject to Plan.    The Award Shares acquired hereunder are subject to the Plan, the terms
and provisions of which, as it may be amended from time to time, are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or
provision of the Plan, the Plan will govern and prevail. 

2

 

        Section 6.    Tax Withholding.    The Company's obligation to issue and deliver the Award Shares to the
Participant is subject to the making of provision for the payment or withholding of any taxes required to be withheld pursuant to any applicable law in respect of the receipt or lapse of forfeiture
restrictions with respect to such shares. 

        Section 7.    Section 83(b) Election.    The Participant shall promptly (and not later than
30 days of the date hereof) notify the Company if the Participant makes an election under section 83(b) of the Internal Revenue Code. 

        Section 8.    Investment Representation.    Upon acquisition of Award Shares under the Plan at a time when
there is not in effect a registration statement under the Securities Act of 1933, as amended, relating to the shares of Common Stock, the Participant hereby represents and warrants, and by virtue of
such
acquisition shall be deemed to represent and warrant, to the Company that the Award Shares shall be acquired for investment and not with a view to the distribution thereof, and not with any present
intention of distributing the same, and the Participant shall provide the Company with such further representations and warranties as the Company may require in order to ensure compliance with
applicable federal and state securities, blue sky and other laws. No Award Shares shall be acquired unless and until the Company and/or the Participant shall have complied with all applicable federal
or state registration, listing and/or qualification requirements and all other requirements of law or of any regulatory agencies having jurisdiction, unless the Board has received evidence
satisfactory to it that the Participant may acquire such shares pursuant to an exemption from registration under the applicable securities laws. Any determination in this connection by the Board shall
be final, binding, and conclusive. The Company reserves the right to legend any certificate for shares of Common Stock, conditioning sales of such shares upon compliance with applicable federal and
state securities laws and regulations. 

        Section 9.    Changes in Common Stock.    Any right of the Participant or the Company hereunder with respect to
the Award Shares shall also apply to any other shares of stock of the Company into which the Common Stock has been exchanged or converted, or which were issued in respect thereof, pursuant to any
recapitalization or other event referred to in Section 11 of the Plan, as determined by the Board in accordance with the Plan. 

        Section 10.    No Right of Service.    Nothing in this Award Agreement shall confer upon the Participant any
right to continue in the service of the Company or to interfere in any way with the right of the Company or the shareholders of the Company to terminate the Participant's service at any time. 

        Section 11.    Notices.    Any notice hereunder by the Participant shall be given to the Company in writing and
such notice shall be deemed duly given only upon receipt thereof by the Company's general counsel at the Company's office at 3280 Bayshore Blvd., Brisbane, California 94005, or at such other address
as the Company may designate by notice to the Participant. Any notice hereunder by the Company shall be given to the Participant in writing and such notice shall be deemed duly given only upon receipt
thereof at such address as the Participant may have on file with the Company. 

        Section 12.    Construction.    The Board shall have the discretionary authority for the interpretation and
construction of this Agreement, as and in the manner set forth in Section 3 of the Plan. 

        Section 13.    Governing Law.    This Award Agreement shall be construed and enforced in accordance with the
laws of the State of Delaware, without giving effect to the choice of law principles thereof. 

        Section 14.    Integration.    As of the date hereof, this Award Agreement and the Plan set forth the entire
understanding between the Participant and the Company regarding the matters set forth herein, and supersede and merge all prior discussions and oral and written agreements between the Participant and
the Company. 

3

 

        Section 15.    Counterparts.    This Award Agreement may be signed in counterparts, which signatures, taken as
a whole, shall constitute an effective agreement. 

*        *        *

        WHEREBY,
the parties have entered into this Agreement as of the dates set forth below: 

	 	INTERMUNE, INC.
	

 	

By:	
 	

/s/  STEPHEN N. ROSENFIELD      
 Name: Stephen N. Rosenfield

Title: Executive Vice President of Legal Affairs
	

 	

Date:	
 	

11/19/03
	

 	

PARTICIPANT
	

 	

/s/  WILLIAM R. RINGO      

	 	Name:	 	William R. Ringo, Jr.
	

 	

Date:	
 	

Nov 19, 2003

4

QuickLinks

Exhibit 10.69QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.70    
    

November 26,
2003 

VIA PERSONAL DELIVERY  

John
Wulf

1816 El Verano Way

Belmont, CA 94002 

Dear
John: 

This
letter sets forth the substance of the separation agreement (the "Agreement") that InterMune, Inc. (the "Company") is offering to you to aid
in your employment transition. 

        1.    Separation.    Your last day of employment with the Company was November 10, 2003 (the "Separation
Date"). 

        2.    Accrued Salary and Paid Time Off.    On the Separation Date, the Company paid to you all accrued salary, and all
accrued and unused vacation earned through the Separation Date, subject to standard payroll deductions and withholdings. You were entitled to these payments regardless of whether or not you sign this
Agreement. 

        3.    Severance Benefits.    

        (a)   Under
your offer letter with the Company, dated May 15, 2000 ("Offer Letter"), you are entitled to the continuation of your base salary for a period of six months
after your termination other than for cause. Thus, the Company will make severance payments to you in an aggregate amount equal to $77,903.16 (the "Severance"), which constitutes: (a) six
months of your base salary in effect on the Separation Date, less (b) the standard payroll deductions and withholdings
(i.e., your net salary). This Severance will be paid to you as follows: 

	i.
	On
or prior to December 31, 2003, you will be paid an amount equal to $22,391.48 (i.e., your base salary from the
day after the Severance Date through the end of the year, less withholdings), in one or more payments at the Company's option; and

	ii.
	On
or prior to January 9, 2004, you will be paid the remainder of the Severance in a lump sum equal to $55,511.68. 

        (b)   Further,
on or prior to January 9, 2004, the Company will pay to you an additional $66,687.52, less standard
withholdings. 

        4.    Health Insurance.    To the extent provided by the federal COBRA law or, if applicable, state insurance laws,
and by the Company's current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense. Later, you may be able to convert to an
individual policy through the provider of the Company's health insurance, if you wish. As part of this Agreement and as provided in your Offer Letter, the Company will pay the premiums necessary to
continue your current health insurance coverage through May 10, 2004. 

        5.    Stock Options.    You were granted certain options to purchase shares of the Company's common stock, pursuant to
the governing Stock Option Agreements and the Company's 2000 Equity Incentive Plan (the "Plan"). Under the terms of the Plan and your Stock Option Agreements, 133,749 of your options will have vested
as of the Separation Date. Your Offer Letter provides that your options will continue to vest for six months following your termination other than for cause
(i.e., amounting to options for the purchase of 38,748 shares of the Company's common stock). However, the Company has agreed that these 38,748 options
will instead become fully vested upon the Effective Date, as further consideration for this Agreement. You will have until 12:01 a.m. on November 10, 2004 to exercise any of the vested
options described in this Paragraph 5. 

        6.    Outplacement.    After the Effective Date, the Company will pay an outplacement firm an amount not to exceed
$7,500 for outplacement assistance to be provided to you. 

 

        7.    Other Compensation or Benefits.    You acknowledge that, except as expressly provided in this Agreement, you
will not receive any additional compensation, severance or benefits after the Separation Date. 

        8.    Expense Reimbursements.    You have submitted your final documented expense reimbursement statement reflecting
all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse you for these expenses pursuant to its regular business practice. 

        9.    Return of Company Property.    You have returned to the Company all Company documents (and all copies thereof)
and other Company property that you have had in your possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial
information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit cards, entry cards, identification badges and keys; and, any materials
of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof). 

        10.    Proprietary Information Obligations.    Both during and after your employment, you acknowledge and will abide
by all of your continuing obligations under your Proprietary Information and Inventions Agreement, including your obligation not to use or disclose any confidential or proprietary information of the
Company without prior written authorization from a duly authorized representative of the Company. A copy of your Proprietary Information and Inventions Agreement is attached hereto as  Exhibit A.

        11.    Confidentiality.    The provisions of this Agreement will be held in strictest confidence by you and the
Company and will not be publicized or disclosed in any manner whatsoever; provided, however, that: (a) you may disclose this Agreement in
confidence to your immediate family; (b) the parties may disclose this Agreement in confidence to their respective attorneys, accountants, auditors, tax preparers, and financial advisors;
(c) the Company may disclose this Agreement as necessary to fulfill standard or legally required corporate reporting or disclosure requirements; and (d) the parties may disclose this
Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by
law. In particular, and without limitation, you agree not to disclose the terms of this Agreement to any current or former Company employee. 

        12.    Nondisparagement.    You agree not to disparage the Company or its officers, directors, employees, stockholders
and agents, in any manner likely to be harmful to them or their business, business reputation, or personal reputation. The Company (through its officers and directors) agrees not to discuss or
disparage you in any manner likely to be harmful to your business, business reputation, or personal reputation. Notwithstanding the foregoing, it shall not violate the provisions of this
Section 12 for you or the Company to respond accurately and fully to any question, inquiry, or request for information when required by legal process. 

        13.    Cooperation.    You agree to assist the Company in every proper way with any pending or threatened litigation
in which you may have factual knowledge relevant to the matter. You agree to assist the Company by attending meetings, preparing and signing affidavits, attending informal interviews, providing
deposition or trial testimony, and other similar acts as requested by the Company. You acknowledge and agree that you are expected only to provide truthful and accurate information and testimony in
connection with your obligations as set forth in this Paragraph 13. You further agree to assist the Company with any transitional matters relating to the termination of your employment by
making yourself available by telephone as reasonably requested by the Company. 

        14.    Release.    

        (a)    Release by You.    In exchange for the benefits you are receiving under the terms of this Agreement to which
you would not otherwise be entitled, you hereby generally and completely release 

2

 

the
Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent or subsidiary entities, insurers, affiliates and assigns from any and
all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions prior to or on the date you sign this Agreement.
This general release includes, but is not limited to: (1) all claims arising out of or in any way related to your employment with the Company or the termination of that employment;
(2) all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock,
stock options or any other ownership interests in the Company; (3) all claims for breach of contract, wrongful termination or breach of the implied covenant of good faith and fair dealing;
(4) all tort claims, including claims for fraud, defamation, emotional distress and discharge in violation of public policy; and (5) all federal, state, and local statutory claims,
including claims for discrimination, harassment, retaliation, attorneys' fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities
Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) ("ADEA"), or the California Fair Employment & Housing Act. 

        (b)    Release by the Company.    In exchange for the consideration under this Agreement, the Company hereby releases
you of and from any and all claims or potential claims, liabilities and obligations, both known and unknown, arising out of or in any way related to events, acts, conduct, or omissions that arose
within the course and scope of your employment, prior to or on the date you sign this Agreement. Notwithstanding the release in the preceding sentence, the Company is not waiving its rights to enforce
the provisions of this Agreement. 

        15.    Waiver Of Unknown Claims.    In giving its release, which includes claims that may be unknown to a party to
this agreement at present, each party acknowledges that he or it has read and understand Section 1542 of the California Civil Code which reads as follows: "A general
release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his
settlement with the debtor." Each party expressly waives and relinquishes all rights and benefits under that section and any law of any jurisdiction of similar effect with
respect to the party's release of claims herein, including but not limited to the party's release of any unknown or unsuspected claims he or it may have against the other party. 

        16.    ADEA Waiver.    You hereby acknowledge that you are knowingly and voluntarily waiving and releasing any rights
you may have under the ADEA, and that the consideration given for the foregoing waiver is in addition to anything of value to which you were already entitled. You have been advised by this writing, as
required by the ADEA that: (a) your waiver and release do not apply to any claims that may arise after your signing of this Agreement; (b) you should consult with an attorney prior to
executing this release; (c) you have twenty-one (21) days within which to consider this release (although you may choose to voluntarily execute this release earlier);
(d) you have seven (7) days following the execution of this release to revoke the Agreement; and (e) this Agreement will not be effective until the eighth
day after this Agreement has been signed both by you and by the Company ("Effective Date"). 

        17.    Arbitration.    To ensure rapid and economical resolution of any disputes which may arise under this Agreement
(with the sole exception of disputes involving enforcement of the Proprietary Information and Inventions Agreement), you and the Company agree that any and all disputes or controversies of any nature
whatsoever, arising from or regarding the interpretation, performance, enforcement or breach of this Agreement shall be resolved by confidential, final and binding arbitration (rather than trial by
jury or court or resolution in some other forum). Any arbitration proceeding pursuant to this Agreement shall be conducted by Judicial Arbitration and Mediation Services, Inc. ("JAMS") in San
Francisco, California, under the then-existing JAMS rules. The prevailing party in such arbitration proceedings shall be entitled to recover from the other party reasonable attorneys'
fees, arbitration expenses and other recoverable costs incurred in connection with such arbitration 

3

 

proceeding.
Nothing in this Agreement shall prevent either party from seeking to obtain injunctive relief in court to preserve the status quo or prevent irreparable harm pending the conclusion of any
such arbitration. 

        18.    Miscellaneous.    This Agreement, including Exhibit A,
constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to this subject matter. This Agreement fully incorporates any relevant
provisions of and supersedes the Offer Letter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any
other such promises, warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement
will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any
provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question
will be modified by the court so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of
California as applied to contracts made and to be performed entirely within California. 

4

 

If
this Agreement is acceptable to you, please sign below and return the originals of both to me. 

I
wish you good luck in your future endeavors. 

Sincerely,

INTERMUNE, INC.

	By:	 	/s/  FRED SCHREIBER      
 Fred Schreiber

Senior Vice President of Human Resources	 	 

Exhibit A—Proprietary Information and Inventions Agreement 

ACCEPTED AND AGREED:

	/s/  JOHN J. WULF      
 John Wulf	 	 

Dated:
11/30/03 

5

   Exhibit A

PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT  

 INTERMUNE PHARMACEUTICALS, INC.  

 EMPLOYEE PROPRIETARY INFORMATION

AND INVENTIONS AGREEMENT  

        In consideration of my employment or continued employment by INTERMUNE PHARMACEUTICALS, INC. (the
"Company"), and the compensation now and hereafter paid to me, I hereby agree as follows: 

1.     NONDISCLOSURE  

        1.1    Recognition of Company's Rights; Nondisclosure.    At all times during my employment and thereafter, I will
hold in strictest confidence and will not disclose, use, lecture upon or publish any of the Company's Proprietary Information (defined below), except as such disclosure, use or publication may be
required in connection with my work for the Company, or unless an officer of the Company expressly authorizes such in writing. I will obtain Company's written approval before publishing or submitting
for publication any material (written, verbal, or otherwise) that relates to my work at Company and/or incorporates any Proprietary Information. I hereby assign to the Company any rights I may have or
acquire in such Proprietary Information and recognize that all Proprietary Information shall be the sole property of the Company and its assigns. 

        1.2    Proprietary Information.    The term "Proprietary Information"
shall mean any and all confidential and/or proprietary knowledge, data or information of the Company. By way of illustration but not limitation, "Proprietary
Information" includes (a) trade secrets, inventions, mask works, ideas, processes, formulas, source and object codes, data, programs, other works of authorship,
know-how, improvements, discoveries, developments, designs and techniques (hereinafter collectively referred to as "Inventions"); and
(b) information regarding plans for research, development,
new products, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers; and (c) information regarding the skills
and compensation of other employees of the Company. Notwithstanding the foregoing, it is understood that, at all such times, I am free to use information which is generally known in the trade or
industry, which is not gained as result of a breach of this Agreement, and my own, skill, knowledge, know-how and experience to whatever extent and in whichever way I wish. 

        1.3    Third Party Information.    I understand, in addition, that the Company has received and in the future will
receive from third parties confidential or proprietary information ("Third Party Information") subject to a duty on the Company's part to maintain the
confidentiality of such information and to use it only for certain limited purposes. During the term of my employment and thereafter, I will hold Third Party Information in the strictest confidence
and will not disclose to anyone (other than Company personnel who need to know such information in connection with their work for the Company) or use, except in connection with my work for the
Company, Third Party Information unless expressly authorized by an officer of the Company in writing. 

        1.4    No Improper Use of Information of Prior Employers and Others.    During my employment by the Company I will not
improperly use or disclose any confidential information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto
the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom I have an obligation of confidentiality unless consented to in
writing by that former employer or person. I will use in the performance of my duties only information which is generally known and used by persons with training and experience 

6

 

comparable
to my own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. 

2.     ASSIGNMENT OF INVENTIONS.  

        2.1    Proprietary Rights.    The term "Proprietary Rights" shall mean
all trade secret, patent, copyright, mask work and other intellectual property rights throughout the world. 

        2.2    Prior Inventions.    Inventions, if any, patented or unpatented, which I made prior to the commencement of my
employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, I have set forth on Exhibit B
(Previous Inventions) attached hereto a complete list of all Inventions that I have, alone or jointly with others, conceived, developed or
reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my employment with the Company, that I consider to be my property or the property of third
parties and that I wish to have excluded from the scope of this Agreement (collectively referred to as "Prior Inventions"). If disclosure of any such
Prior Invention would cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in  Exhibit B but am only to disclose a cursory name for each
such invention, a listing of the party(ies) to whom it belongs and the fact that full
disclosure as to such inventions has not been made for that reason. A space is provided on Exhibit B for such purpose. If no such disclosure is
attached, I represent that there are no Prior Inventions. If, in the course of my employment with the Company, I incorporate a Prior Invention into a Company product, process or machine, the Company
is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple tiers of sublicensees) to make, have
made, modify, use and sell such Prior Invention. Notwithstanding the foregoing, I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions without
the Company's prior written consent. 

        2.3    Assignment of Inventions.    Subject to Sections 2.4, and 2.6, I hereby assign and agree to assign in the
future (when any such Inventions or Proprietary Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to the Company all my right, title and interest in and to any
and all Inventions (and all Proprietary Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned
by me, either alone or jointly with others, during the period of my employment with the Company. Inventions assigned to the Company, or to a third party as directed by the Company pursuant to this
Section 2, are hereinafter referred to as "Company Inventions." 

        2.4    Nonassignable Inventions.    This Agreement does not apply to an Invention which qualifies fully as a
nonassignable Invention under Section 2870 of the California Labor Code (hereinafter "Section 2870"). I have reviewed the notification on  Exhibit A (Limited Exclusion Notification) and agree that my signature acknowledges receipt of the notification. 

        2.5    Obligation to Keep Company Informed.    During the period of my employment and for six (6) months after
termination of my employment with the Company, I will promptly disclose to the Company fully and in writing all Inventions authored, conceived or reduced to practice by me, either alone or jointly
with others. In addition, I will promptly disclose to the Company all patent applications filed by me or on my behalf within a year after termination of employment. At the time of each such
disclosure, I will advise the Company in writing of any Inventions that I believe fully qualify for protection under Section 2870; and I will at that time provide to the Company in writing all
evidence necessary to substantiate that belief. The Company will keep in confidence and will not use for any purpose or disclose to third parties without my consent any confidential information
disclosed in writing to the Company pursuant to this Agreement relating to Inventions that qualify fully for protection under the provisions of Section 2870. I will preserve the confidentiality
of any Invention that does not fully qualify for protection under Section 2870. 

7

 

        2.6    Government or Third Party.    I also agree to assign all my right, title and interest in and to any particular
Company Invention to a third party, including without limitation the United States, as directed by the Company. 

        2.7    Works for Hire.    I acknowledge that all original works of authorship which are made by me (solely or jointly
with others) within the scope of my employment and which are protectable by copyright are "works made for hire," pursuant to United States Copyright Act (17 U.S.C., Section 101). 

        2.8    Enforcement of Proprietary Rights.    I will assist the Company in every proper way to obtain, and from time to
time enforce, United States and foreign Proprietary Rights relating to Company Inventions in any and all countries. To that end I will execute, verify and deliver such documents and perform such other
acts (including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the
assignment thereof. In addition, I will execute, verify and deliver assignments of such Proprietary Rights to the Company or its designee. My obligation to assist the Company with respect to
Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of my employment, but the Company shall compensate me at a reasonable rate after
my termination for the time actually spent by me at the Company's request on such assistance. 

        In
the event the Company is unable for any reason, after reasonable effort, to secure my signature on any document needed in connection with the actions specified in the preceding
paragraph, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act
for and in my behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect
as if executed by me. I hereby waive and quitclaim to the Company any and all claims, of any nature whatsoever, which I now or may hereafter have for infringement of any Proprietary Rights assigned
hereunder to the Company. 

        2.9    Records.    I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings
and in any other form that may be required by the Company) of all Proprietary Information developed by me and all Inventions made by me during the period of my employment at the Company, which records
shall be available to and remain the sole property of the Company at all times. 

        2.10    Additional Activities.    I agree that during the period of my employment by the Company I will not, without
the Company's express written consent, engage in any employment or business activity which is competitive with, or would otherwise conflict with, my employment by the Company. I agree further that for
the period of my employment by the Company and for one (l) year after the date of termination of my employment by the Company I will not induce any employee of the Company to leave the employ
of the Company. 

        2.11    No Conflicting Obligation.    I represent that my performance of all the terms of this Agreement and as an
employee of the Company does not and will not breach any agreement to keep in confidence information acquired by me in confidence or in trust prior to my employment by the Company. I have not entered
into, and I agree I will not enter into, any agreement either written or oral in conflict herewith. 

        2.12    Return of Company Documents.    When I leave the employ of the Company, I will deliver to the Company any and
all drawings, notes, memoranda, specifications, devices, formulas, and documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party
Information or Proprietary Information of the Company. I further agree that any property situated on the Company's premises and owned by the Company, including disks and other storage media, filing
cabinets or other work areas, is subject to inspection by Company 

8

 

personnel
at any time with or without notice. Prior to leaving, I will cooperate with the Company in completing and signing the Company's termination statement. 

        2.13    Legal and Equitable Remedies.    Because my services are personal and unique and because I may have access to
and become acquainted with the Proprietary Information of the Company, the Company shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other
equitable relief, without bond and without prejudice to any other rights and remedies that the Company may have for a breach of this Agreement. 

        2.14    Notices.    Any notices required or permitted hereunder shall be given to the appropriate party at the address
specified below or at such other address as the party shall specify in writing. Such notice shall be deemed given upon personal delivery to the appropriate address or if sent by certified or
registered mail, three (3) days after the date of mailing. 

        2.15    Notification of New Employer.    In the event that I leave the employ of the Company, I hereby consent to the
notification of my new employer of my rights and obligations under this Agreement. 

3.     GENERAL PROVISIONS.  

        3.1    Governing Law; Consent to Personal Jurisdiction.    This Agreement will be governed by and construed according
to the laws of the State of California, as such laws are applied to agreements entered into
and to be performed entirely within California between California residents. I hereby expressly consent to the personal jurisdiction of the state and federal courts located in Santa Clara County,
California for any lawsuit filed there against me by Company arising from or related to this Agreement. 

        3.2    Severability.    In case any one or more of the provisions contained in this Agreement shall, for any reason,
be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be
construed as if such invalid, illegal or unenforceable provision had never been contained herein. If moreover, any one or more of the provisions contained in this Agreement shall for any reason be
held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the
applicable law as it shall then appear. 

        3.3    Successors and Assigns.    This Agreement will be binding upon my heirs, executors, administrators and other
legal representatives and will be for the benefit of the Company, its successors, and its assigns. 

        3.4    Survival.    The provisions of this Agreement shall survive the termination of my employment and the assignment
of this Agreement by the Company to any successor in interest or other assignee. 

        3.5    Employment.    I agree and understand that nothing in this Agreement shall confer any right with respect to
continuation of employment by the Company, nor shall it interfere in any way with my right or the Company's right to terminate my employment at any time, with or without cause. 

        3.6    Waiver.    No waiver by the Company of any breach of this Agreement shall be a waiver of any preceding or
succeeding breach. No waiver by the Company of any right under this Agreement shall be construed as a waiver of any other right. The Company shall not be required to give notice to enforce strict
adherence to all terms of this Agreement. 

        3.7    Entire Agreement.    The obligations pursuant to Sections 1 and 2 of this Agreement shall apply to any time
during which I was previously employed, or am in the future employed, by the Company as a consultant if no other agreement governs nondisclosure and assignment of inventions during such period. This
Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior discussions between us. No modification of or
amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the party to be charged. Any subsequent change or changes in my
duties, salary or compensation will not affect the validity or scope of this Agreement. 

9

 

        This
Agreement shall be effective as of the first day of my employment with the Company, namely: /s/ June 8, 2000. 

        I HAVE READ THIS AGREEMENT CAREFULLY AND UNDERSTAND ITS TERMS. I HAVE COMPLETELY FILLED OUT EXHIBIT B TO THIS AGREEMENT.

	/s/  JOHN J. WULF      
(Signature)	 	 
	

John J. Wulf
(Printed Name)	
 	

 

	Address:	1816 Verano Way

Belmont, CA 94002	 	 

	Dated:	6/12/00	 	 

ACCEPTED AND AGREED TO:  

INTERMUNE PHARMACEUTICALS, INC.  

	By:	/s/  M. CRETAROLO      
	 	 

	Title:	Senior Manager, HR
	 	 

	Address:	3294 West Bayshore Road

Palo Alto, CA 94303	 	 

	Dated:	6/12/00	 	 

10

   Exhibit A  

 LIMITED EXCLUSION NOTIFICATION  

        This is to notify you in accordance with Section 2872 of the California Labor Code that the foregoing
Agreement between you and the Company does not require you to assign or offer to assign to the Company any invention that you developed entirely on your own time without using the Company's equipment,
supplies, facilities or trade secret information except for those inventions that either: 

        1.     Relate
at the time of conception or reduction to practice of the invention to the Company's business, or actual or demonstrably anticipated research or development of the
Company; 

        2.     Result
from any work performed by you for the Company. 

        To
the extent a provision in the foregoing Agreement purports to require you to assign an invention otherwise excluded from the preceding paragraph, the provision is against the public
policy of this state and is unenforceable. 

        This
limited exclusion does not apply to any patent or invention covered by a contract between the Company and the United States or any of its agencies requiring full title to such
patent or invention to be in the United States. 

        I acknowledge receipt of a copy of this notification. 

	 	 	By:	/s/  JOHN J. WULF      
(Printed Name of Employee)

	

 	
 	

Date:	

6/12/00

	 
	 	 

	Witnessed by:	 	 
	

/s/  BEE NGUYEN      
(Printed Name of Representative)	
 	

 

A-1

   Exhibit B  

	 
	 	 
	 	 

	TO:	 	InterMune Pharmaceuticals, Inc.	 	 
	

FROM:	
 	

/s/  JOHN J. WULF      
	
 	

 
	

DATE:	
 	

6/12/00
	
 	

 
	

SUBJECT:	
 	

Previous Inventions	
 	

 

        1.     Except as listed in Section 2 below, the following is a complete list of all inventions or improvements relevant to
the subject matter of my employment by InterMune Pharmaceuticals, Inc. (the "Company") that have been made or conceived or first reduced to practice by me alone or jointly with others prior to
my engagement by the Company: 

	 
	 

	x	No inventions or improvements.
	

o	

See below:
	

 	

	

 	

	

 	

o    Additional
sheets attached. 

        2.     Due to a prior confidentiality agreement, I cannot complete the disclosure under Section 1 above with respect to
inventions or improvements generally listed below, the proprietary rights and duty of confidentiality with respect to which I owe to the following party(ies): 

	 
	 	 
	 	 
	 	 

	 	 	Invention or Improvement	 	Party(ies)	 	Relationship
	

1.	
 	

 	
 	

 	
 	

 
	 	 	
	 	
	 	

	
2.	
 	

 	
 	

 	
 	

 
	 	 	
	 	
	 	

	
3.	
 	

 	
 	

 	
 	

 
	 	 	
	 	
	 	

	

o	
 	

Additional sheets attached.	
 	

 	
 	

 

B-1

QuickLinks

Exhibit 10.70

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}]]